TERRANOVA, CORRADO
 Distribuzione geografica
Continente #
AS - Asia 5.678
NA - Nord America 889
EU - Europa 399
SA - Sud America 29
AF - Africa 8
OC - Oceania 7
Totale 7.010
Nazione #
SG - Singapore 4.947
US - Stati Uniti d'America 837
CN - Cina 369
HK - Hong Kong 301
IT - Italia 117
GB - Regno Unito 108
DE - Germania 67
CA - Canada 38
BR - Brasile 21
CZ - Repubblica Ceca 18
IN - India 18
NL - Olanda 18
FR - Francia 13
MX - Messico 12
JP - Giappone 10
EE - Estonia 9
FI - Finlandia 9
TR - Turchia 8
ES - Italia 7
SE - Svezia 7
ZA - Sudafrica 7
AU - Australia 6
PL - Polonia 6
CL - Cile 4
TW - Taiwan 4
AT - Austria 3
BD - Bangladesh 3
KR - Corea 3
UA - Ucraina 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
EC - Ecuador 2
HR - Croazia 2
ID - Indonesia 2
MK - Macedonia 2
RS - Serbia 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
GR - Grecia 1
IE - Irlanda 1
IQ - Iraq 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 7.010
Città #
Hong Kong 299
Singapore 215
Hefei 214
Ashburn 205
Boardman 114
London 85
Shanghai 68
Santa Clara 66
Rome 62
Beijing 54
Los Angeles 35
San Francisco 34
Munich 33
Washington 21
Buffalo 20
Brno 18
Montreal 18
Council Bluffs 16
Toronto 16
Amsterdam 13
Seattle 13
Secaucus 12
Brooklyn 10
Chicago 10
Pune 10
Grumo Nevano 9
Tokyo 9
Boston 8
New York 8
Paris 8
Johannesburg 7
São Paulo 7
Coral Springs 6
Warsaw 6
Mexico City 5
Naples 5
Phoenix 5
Stockholm 5
Temecula 5
Canberra 4
Catania 4
Helsinki 4
Taipei 4
The Dalles 4
Turku 4
Charlotte 3
Cusano Milanino 3
Dallas 3
Las Vegas 3
Louisville 3
Mysore 3
Newark 3
Seoul 3
Sonoma 3
Zhengzhou 3
Ankara 2
Brusaporto 2
Buford 2
Calgary 2
Chennai 2
Cleveland 2
Columbia 2
Cuautitlán Izcalli 2
Edinburgh 2
Elk Grove Village 2
Faella 2
Hanover 2
Ho Chi Minh City 2
Hyderabad 2
Leeds 2
Linköping 2
Manchester 2
Novi Sad 2
Nuremberg 2
Oklahoma City 2
Pittsburgh 2
Poplar 2
Riyadh 2
Salerno 2
San Jose 2
Skopje 2
Tallinn 2
Wandsworth 2
Zagreb 2
Arlington 1
Atlanta 1
Auckland 1
Baghdad 1
Bandar Seri Begawan 1
Berlin 1
Bratislava 1
Buenos Aires 1
Central 1
Charleston 1
Chengdu 1
Chungathara 1
Cicciano 1
City of London 1
Clifton 1
Curitiba 1
Totale 1.882
Nome #
A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial 208
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 207
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies 204
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 200
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 199
The challenge of preoperative identification of uterine myomas: Is ultrasound trustworthy? A prospective cohort study 199
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 199
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 196
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 195
Analysis of ultrasonographic and hystopathologic features of placental invasiveness in Vitro Fertilization (IVF) pregnancies: a prospective study 191
Human embryo: what about relatedness? 190
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 187
Does HE4 have a role in the recurrence of ovarian cancer? 183
Intraoperative contact ultrasonography during open myomectomy for uterine fibroids 182
Chronic subtorsion of the ovary with subsequent ovarian hypoplasia 180
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 179
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 175
Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study 175
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 170
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 165
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 163
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 106
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 102
A critical review on HE4 performance in endometrial cancer: where are we now? 102
A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection 100
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 93
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 91
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 90
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 89
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 88
A new type of absorbable barbed suture for use in laparoscopic myomectomy 88
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 86
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 86
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 84
Assessing HPV vaccination perceptions with online social media in Italy 84
[The role of laparoscopy in ovarian carcinoma]. 84
Chirurgia Benigna 83
Economic impact among family caregivers of patients with advanced ovarian cancer 82
Impact of COVID-19 Pandemic on the Diagnostic and Therapeutic Management of Endometrial Cancer: A Monocentric Retrospective Comparative Study 78
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 77
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study 75
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 34
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 32
The role of ovarian fossa evaluation in patients with ovarian endometriosis 31
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 31
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 31
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 29
Ovarian cancer relapse: From the latest scientific evidence to the best practice 27
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 27
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 26
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 26
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 26
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 26
Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial 26
The Rendezvous Technique: A Minimally Invasive Non-Surgical Approach for the Management of Iatrogenic Ureteral Injuries 25
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 24
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 24
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 24
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program 24
Ten years of HPV vaccines: State of art and controversies 24
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. 23
Miomectomia laparoscopica: fattibilità e learning curve 23
PREOPERATIVE LOCAL STAGING OF ENDOMETRIAL CANCER: THE CHALLENGE OF IMAGING TECHNIQUES AND SERUM BIOMARKERS 23
Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test 22
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 22
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 22
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 22
The role of macroplastique implantation in the management of occult urinary stress incontinence 22
Real-time infrared thermography for ureter detection during hysterectomy 22
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature 21
The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study 21
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 21
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers 21
Dual HER2/PIK3CA targeting overcomes single-agent acquired resistance in HER2-amplified uterine serous carcinoma cell lines in vitro and in vivo 20
Hormone replacement therapy in cancer survivors: Utopia? 20
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 20
The Role of Novel Serum Biomarker HE4 in Endometrial Cancer 20
Studio prospettico randomizzato comparativo tra due tecniche 20
TOTAL RECTOSIGMOIDECTOMY VERSUS PARTIAL RECTAL RESECTION IN ADVANCED OVARIAN CANCER SURGICAL DEBULKING: A CASE CONTROL STUDY 20
Laparoscopic myomectomy learning curve safety and feasibility. 20
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 20
ROBOTIC PELVIC LYMPHADENECTOMY: STEPS AND TECHNIQUE 20
NOVEL BIOMARKER HE4 IN PREDICTING OPTIMAL CYTOREDUCTION AFTER NEO-ADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CANCER 19
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 19
RANDOMIZED CONTROL TRIAL COMPARING FOUR VERSUS SIX COURSES OF ADJUVANT PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PREVIOUSLY TREATED WITH NEO-ADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY 19
Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature 18
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 18
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women 18
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 18
REM (RISK OF ENDOMETRIAL MALIGNANCY): A PROPOSAL FOR A NEW SCORING SYSTEM TO EVALUATE RISK OF ENDOMETRIAL MALIGNANCY 17
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 17
Studio prospettico randomizzato comparativo tra due tecniche chirurgiche per il trattamento dell’incontinenza urinaria da sforzo: accesso retropubico vs transotturatorio 17
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 16
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis 16
The role of novel serum biomarker HE4 in endometrial cancer 16
Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy 16
Pre-Operative Staging:What Is the Cost-Effective Workup? 15
Is there only CO2 insufflation pressure impact on surgical field visualization during robotic surgery? Reply 15
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 14
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 14
Totale 6.999
Categoria #
all - tutte 40.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 3 1 0 0 1 4 4 3 0 122
2022/202351 0 0 1 2 1 1 12 2 3 3 17 9
2023/2024491 10 42 46 43 43 147 4 64 9 20 30 33
2024/20255.948 107 25 122 33 27 98 84 69 277 347 2.304 2.455
2025/2026431 316 115 0 0 0 0 0 0 0 0 0 0
Totale 7.059